vs
Guidewire Software, Inc.（GWRE）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是Guidewire Software, Inc.的1.9倍（$622.0M vs $332.6M），Royalty Pharma plc净利率更高（34.4% vs 9.4%，领先25.0%），Guidewire Software, Inc.同比增速更快（26.5% vs 4.8%），过去两年Guidewire Software, Inc.的营收复合增速更高（17.5% vs 4.6%）
Guidewire Software是总部位于美国加利福尼亚州圣马特奥的软件企业，面向美国及全球的财产与意外伤害保险经营机构提供专业行业平台，支持险企优化业务流程、推进数字化升级，满足保险行业的各类专业化运营需求。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
GWRE vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.9倍
$332.6M
营收增速更快
GWRE
高出21.8%
4.8%
净利率更高
RPRX
高出25.0%
9.4%
两年增速更快
GWRE
近两年复合增速
4.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $332.6M | $622.0M |
| 净利润 | $31.3M | $214.2M |
| 毛利率 | 63.0% | — |
| 营业利润率 | 5.6% | 62.4% |
| 净利率 | 9.4% | 34.4% |
| 营收同比 | 26.5% | 4.8% |
| 净利润同比 | 242.6% | 2.9% |
| 每股收益（稀释后） | $0.36 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GWRERPRX
| Q4 25 | $332.6M | $622.0M | ||
| Q3 25 | $356.6M | $609.3M | ||
| Q2 25 | $293.5M | $578.7M | ||
| Q1 25 | $289.5M | $568.2M | ||
| Q4 24 | $262.9M | $593.6M | ||
| Q3 24 | $291.5M | $564.7M | ||
| Q2 24 | $240.7M | $537.3M | ||
| Q1 24 | $240.9M | $568.0M |
净利润GWRERPRX
| Q4 25 | $31.3M | $214.2M | ||
| Q3 25 | $52.0M | $288.2M | ||
| Q2 25 | $46.0M | $30.2M | ||
| Q1 25 | $-37.3M | $238.3M | ||
| Q4 24 | $9.1M | $208.2M | ||
| Q3 24 | $16.8M | $544.0M | ||
| Q2 24 | $-5.5M | $102.0M | ||
| Q1 24 | $9.7M | $4.8M |
毛利率GWRERPRX
| Q4 25 | 63.0% | — | ||
| Q3 25 | 65.0% | — | ||
| Q2 25 | 62.2% | — | ||
| Q1 25 | 61.9% | — | ||
| Q4 24 | 60.2% | — | ||
| Q3 24 | 64.0% | — | ||
| Q2 24 | 59.1% | — | ||
| Q1 24 | 59.1% | — |
营业利润率GWRERPRX
| Q4 25 | 5.6% | 62.4% | ||
| Q3 25 | 8.3% | 70.1% | ||
| Q2 25 | 1.5% | 36.3% | ||
| Q1 25 | 4.0% | 94.0% | ||
| Q4 24 | -1.8% | 60.9% | ||
| Q3 24 | 3.5% | — | ||
| Q2 24 | -6.9% | 50.2% | ||
| Q1 24 | -5.2% | -13.0% |
净利率GWRERPRX
| Q4 25 | 9.4% | 34.4% | ||
| Q3 25 | 14.6% | 47.3% | ||
| Q2 25 | 15.7% | 5.2% | ||
| Q1 25 | -12.9% | 41.9% | ||
| Q4 24 | 3.5% | 35.1% | ||
| Q3 24 | 5.7% | 96.3% | ||
| Q2 24 | -2.3% | 19.0% | ||
| Q1 24 | 4.0% | 0.8% |
每股收益（稀释后）GWRERPRX
| Q4 25 | $0.36 | $0.49 | ||
| Q3 25 | $0.61 | $0.67 | ||
| Q2 25 | $0.54 | $0.07 | ||
| Q1 25 | $-0.45 | $0.55 | ||
| Q4 24 | $0.11 | $0.46 | ||
| Q3 24 | $0.21 | $1.21 | ||
| Q2 24 | $-0.07 | $0.23 | ||
| Q1 24 | $0.12 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.0B | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $1.5B | $9.7B |
| 总资产 | $2.6B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资GWRERPRX
| Q4 25 | $1.0B | $618.7M | ||
| Q3 25 | $1.1B | $938.9M | ||
| Q2 25 | $920.4M | $631.9M | ||
| Q1 25 | $1.2B | $1.1B | ||
| Q4 24 | $1.3B | $929.0M | ||
| Q3 24 | $1.0B | $950.1M | ||
| Q2 24 | $782.3M | $1.8B | ||
| Q1 24 | $777.6M | $843.0M |
总债务GWRERPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | $398.9M | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益GWRERPRX
| Q4 25 | $1.5B | $9.7B | ||
| Q3 25 | $1.5B | $9.6B | ||
| Q2 25 | $1.4B | $9.5B | ||
| Q1 25 | $1.3B | $9.8B | ||
| Q4 24 | $1.3B | $10.3B | ||
| Q3 24 | $1.3B | $10.3B | ||
| Q2 24 | $1.3B | $9.8B | ||
| Q1 24 | $1.3B | $9.9B |
总资产GWRERPRX
| Q4 25 | $2.6B | $19.6B | ||
| Q3 25 | $2.7B | $19.3B | ||
| Q2 25 | $2.5B | $18.3B | ||
| Q1 25 | $2.5B | $17.6B | ||
| Q4 24 | $2.6B | $18.2B | ||
| Q3 24 | $2.2B | $18.0B | ||
| Q2 24 | $2.0B | $17.7B | ||
| Q1 24 | $2.0B | $16.1B |
负债/权益比GWRERPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | 0.30× | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-67.4M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $-72.3M | — |
| 自由现金流率自由现金流/营收 | -21.7% | — |
| 资本支出强度资本支出/营收 | 1.5% | — |
| 现金转化率经营现金流/净利润 | -2.15× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $286.0M | — |
8季度趋势，按日历期对齐
经营现金流GWRERPRX
| Q4 25 | $-67.4M | $827.1M | ||
| Q3 25 | $244.8M | $702.6M | ||
| Q2 25 | $32.4M | $364.0M | ||
| Q1 25 | $86.0M | $596.1M | ||
| Q4 24 | $-62.3M | $742.5M | ||
| Q3 24 | $193.8M | $703.6M | ||
| Q2 24 | $4.8M | $658.2M | ||
| Q1 24 | $69.3M | $664.6M |
自由现金流GWRERPRX
| Q4 25 | $-72.3M | — | ||
| Q3 25 | $241.4M | — | ||
| Q2 25 | $31.6M | — | ||
| Q1 25 | $85.2M | — | ||
| Q4 24 | $-63.1M | — | ||
| Q3 24 | $192.1M | — | ||
| Q2 24 | $4.1M | — | ||
| Q1 24 | $66.3M | — |
自由现金流率GWRERPRX
| Q4 25 | -21.7% | — | ||
| Q3 25 | 67.7% | — | ||
| Q2 25 | 10.8% | — | ||
| Q1 25 | 29.4% | — | ||
| Q4 24 | -24.0% | — | ||
| Q3 24 | 65.9% | — | ||
| Q2 24 | 1.7% | — | ||
| Q1 24 | 27.5% | — |
资本支出强度GWRERPRX
| Q4 25 | 1.5% | — | ||
| Q3 25 | 1.0% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | 0.6% | — | ||
| Q2 24 | 0.3% | — | ||
| Q1 24 | 1.2% | — |
现金转化率GWRERPRX
| Q4 25 | -2.15× | 3.86× | ||
| Q3 25 | 4.71× | 2.44× | ||
| Q2 25 | 0.70× | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | -6.82× | 3.57× | ||
| Q3 24 | 11.56× | 1.29× | ||
| Q2 24 | — | 6.45× | ||
| Q1 24 | 7.15× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GWRE
| Subscription | $222.7M | 67% |
| Services | $62.4M | 19% |
| Other | $33.1M | 10% |
| Support | $14.5M | 4% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
